Status:
COMPLETED
Evaluating the Impact of Virtual Reality Exposure Therapy on Epilepsy/Seizure-Specific Interictal Anxiety
Lead Sponsor:
University Health Network, Toronto
Conditions:
Epilepsy
Anxiety Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this randomized control trial is to evaluate the impact of Virtual Reality (VR) Exposure Therapy (ET) on people with epilepsy who experience epilepsy/seizure-specific (ES) interictal an...
Detailed Description
BASELINE VISIT #1 (T0): The first study visit will take place at the participant's bedside in the EMU with a member of the research team. The participant will be asked to complete several questionnai...
Eligibility Criteria
Inclusion
- Individuals who are at least 18 years old
- Individuals admitted to the EMU
- Individuals who have self-reported anxiety related to having epilepsy or seizures
- Individuals who score \<15 on the Fast Motion Sickness (FMS) after the VR neutral demo
Exclusion
- Individuals with an unconfirmed epilepsy diagnosis
- Individuals with stereotaxic EEG monitoring
- Individuals with photosensitive epilepsy
- Individuals with open wounds on the face or cervical conditions or injuries that would make it unsafe for use the VR headset
- Individuals who have started an antidepressant, antianxiety drug, or medical marijuana in the last twelve weeks
- Individuals who cannot speak or understand English
Key Trial Info
Start Date :
May 24 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 11 2024
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT06028945
Start Date
May 24 2024
End Date
November 11 2024
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T 2S8